Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
0.7620
-0.0270 (-3.42%)
At close: Aug 1, 2025, 4:00 PM
0.7500
-0.0120 (-1.57%)
After-hours: Aug 1, 2025, 7:54 PM EDT
Instructure Holdings Market Cap
Predictive Oncology has a market cap or net worth of $7.33 million as of August 1, 2025. Its market cap has increased by 52.64% in one year.
Market Cap
7.33M
Enterprise Value
6.16M
1-Year Change
52.64%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since April 9, 2010, Predictive Oncology's market cap has increased from $1.74M to $7.33M, an increase of 320.10%. That is a compound annual growth rate of 9.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 7.33M | 33.99% |
| Dec 31, 2024 | 5.47M | -59.10% |
| Dec 29, 2023 | 13.37M | -44.64% |
| Dec 30, 2022 | 24.15M | -61.32% |
| Dec 31, 2021 | 62.42M | 382.16% |
| Dec 31, 2020 | 12.95M | 26.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |